JPM
JPMorgan Chase & Co.
JPM offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
SRBK
SR Bancorp, Inc. Common stock
SRBK has a slight edge over JPM overall, supported by stronger modeled upside and stronger valuation.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
SRBK Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
SRBK's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like SRBK.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
SRBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 24x | $18.83 | — |
| Cheap | 30x | $15.00 | -20% |
| Fair | 32x | $16.06 | -15% |
| Current | 38x | $18.83 | — |
| Expensive | 41x | $20.75 | +10% |
Historical ranges are pointers, not guarantees.
SRBK has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
SRBK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
SRBK has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over SRBK in the latest year-over-year earnings comparison.
SRBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.77 | +54% |
| Q3 2026 | $0.50 | -7.4% |
| Q2 2026 | $0.44 | -28% |
SRBK earned $0.50 per share over the past year, down 7.4% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over SRBK on profitability, with a higher operating margin.
SRBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.9M | +9.1% |
| Q1 2026 | $8.4M | +8.2% |
| Q4 2025 | $8.4M | +6.4% |
| Q3 2025 | $8.2M | -2.8% |
| Q1 2025 | $7.7M | -12% |
| Q4 2024 | $7.9M | -16% |
| Q3 2024 | $8.4M | +80% |
SRBK has the edge over JPM in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | +5.1 points |
| Q2 2026 | 15% | N/A |
| Q1 2026 | 14% | +5.9 points |
| Q4 2025 | 13% | -4.1 points |
| Q3 2025 | 11% | -9.6 points |
| Q1 2025 | 8.1% | -7.3 points |
| Q4 2024 | 17% | -4.4 points |
| Q3 2024 | 21% | +288 points |
SRBK's operating margin was 16% last quarter, up 5.1 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
SRBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.7M | +140% |
| Q2 2026 | $3.8M | +141% |
| Q1 2026 | $1.9M | -25% |
| Q4 2025 | $3.1M | +$4.6M |
| Q3 2025 | $1.1M | -33% |
| Q2 2025 | $1.6M | -60% |
| Q1 2025 | $2.5M | +345% |
| Q4 2024 | -$1.5M | -$557K |
SRBK has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has 2.7B diluted shares, down 3.1% from a year ago, with $24.5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
SRBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.1% | -311K shares |
| 1 year | -7.6% | -602K shares |
SRBK has the edge over JPM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $328,000 |
| Q2 2026 | $4M |
| Q1 2026 | $5M |
| Q4 2025 | $4.1M |
| Q3 2025 | $2.9M |
| Q2 2025 | $4M |
| Q1 2025 | $3.4M |
| Q4 2024 | $3.2M |
SRBK spent $13M buying back its own shares over the past year, about the same as the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
SRBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -7.9x | Net Cash |
| Q2 2026 | -10.0x | Net Cash |
| Q1 2026 | -7.6x | Net Cash |
| Q4 2025 | -4.4x | Net Cash |
| Q3 2025 | -3.1x | Net Cash |
| Q2 2025 | -3.3x | Net Cash |
| Q1 2025 | -9.2x | Net Cash |
| Q4 2024 | -5.4x | Net Cash |
SRBK has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
SRBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.0 | Neutral |
| Stochastic | 36.0 | Neutral |
SRBK's weekly RSI is 51 (neutral) and its Stochastic is 36 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over SRBK on valuation relative to its sector.
SRBK PE vs Financial Services Sector
| Metric | SRBK | Sector median | Relative |
|---|---|---|---|
| PE | 38x | 13x | 189% above |
| PE % | 79 | 43 | 36 pts above |
SRBK is trading at 38x earnings, a 189% premium to the Financial Services sector's median of 13x.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has stronger trend alignment. JPM is above 4 of 5 weekly averages versus SRBK above 3 of 4.
SRBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.7 | 0.7% above |
| 20 week MA | $19.2 | 2% below |
| 50 week MA | $18.2 | 3.7% above |
| 100 week MA | $15.8 | 19% above |
SRBK's trend is mixed: it's above three of its four weekly moving averages, and 19% above its 100-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
SRBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $9.15 | $9.56 | +4.5% |
| 2024 | $9.56 | $12.1 | +27% |
| 2025 | $12.1 | $16.2 | +34% |
| 2026 YTD | $16.2 | $18.8 | +16% |
SRBK has the edge over JPM on returns for 2026, with the stronger performance.